Clinical Trial Update: Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of the radiotracer [18F]NOTA-ABY030 in indeterminate primary or metastatic head and neck squamous cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• [18F]NOTA-ABY030

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: SCC - Squamous Cell Carcinoma, Radiotracer | Phase 1 | Status: NOT_YET_RECRUITING